2-acetylaminofluorene has been researched along with Papilloma in 7 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Papilloma: A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
" Hence, the levels of statistical significance obtained for dose-response trends and comparisons of treated and control groups were similar using 48 animals per dose groups with B6C3 mice, or combinations of 24 animals per dose from 2 genotypes, or 12 animals per dose from the 4 hybrid genotypes." | 1.28 | Bladder and liver tumorigenesis induced by 2-acetylaminofluorene in different F1 mouse hybrids: variation within genotypes and effects of using more than one genotype on risk assessment. ( Blackwell, BN; Gaylor, DW; Moore, GE; Wolff, GL, 1991) |
"Bladder cancer was also present in rats administered the sequence of FANFT, 2-FAA, and 3,3'-DCB." | 1.26 | Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats. ( Hananouchi, M; Hirose, M; Miyata, Y; Mizutani, M; Tatematsu, M, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MILLER, EC | 1 |
MILLER, JA | 1 |
ENOMOTO, M | 1 |
Williams, GM | 1 |
Maeura, Y | 1 |
Weisburger, JH | 1 |
Chen, JJ | 1 |
Anichkov, NM | 1 |
Tatematsu, M | 1 |
Miyata, Y | 1 |
Mizutani, M | 1 |
Hananouchi, M | 1 |
Hirose, M | 1 |
Matsumoto, M | 1 |
Hopp, ML | 1 |
Oyasu, R | 1 |
Wolff, GL | 1 |
Gaylor, DW | 1 |
Blackwell, BN | 1 |
Moore, GE | 1 |
1 review available for 2-acetylaminofluorene and Papilloma
Article | Year |
---|---|
[Experimental replication of bladder tumors. Morphologic features of early stages of their development].
Topics: 2-Acetylaminofluorene; 2-Naphthylamine; Animals; Butylhydroxybutylnitrosamine; Cell Membrane; Cell T | 1979 |
6 other studies available for 2-acetylaminofluorene and Papilloma
Article | Year |
---|---|
THE COMPARATIVE CARCINOGENICITIES OF 2-ACETYLAMINOFLUORENE AND ITS N-HYDROXY METABOLITE IN MICE, HAMSTERS, AND GUINEA PIGS.
Topics: 2-Acetylaminofluorene; Animals; Carcinogens; Cricetinae; Croton Oil; Fluorenes; Guinea Pigs; Injecti | 1964 |
Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2-fluorenylacetamide by butylated hydroxytoluene.
Topics: 2-Acetylaminofluorene; Animals; Butylated Hydroxytoluene; Carcinoma; Carcinoma, Hepatocellular; Coca | 1983 |
Global tests for analysis of multiple tumour data from animal carcinogenicity experiments.
Topics: 2-Acetylaminofluorene; Adenoma; Animals; Biological Assay; Carcinogenicity Tests; Carcinogens; Carci | 1996 |
Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
Topics: 2-Acetylaminofluorene; 3,3'-Dichlorobenzidine; Animals; Benzidines; Biliary Tract Diseases; Butylhyd | 1977 |
Effect of pair-feeding of carcinogen on the incidence of bladder tumors in hamsters. Role of indole, age, and sex.
Topics: 2-Acetylaminofluorene; Administration, Oral; Age Factors; Animals; Carcinoma; Cricetinae; Diet; Fema | 1976 |
Bladder and liver tumorigenesis induced by 2-acetylaminofluorene in different F1 mouse hybrids: variation within genotypes and effects of using more than one genotype on risk assessment.
Topics: 2-Acetylaminofluorene; Animals; Carcinoma; Female; Genotype; Liver Neoplasms, Experimental; Male; Mi | 1991 |